About Prof. Fu Deliang
Prof. Fu Deliang (傅德良) is the Director of the Department of Pancreatic Surgery at Huashan Hospital, Fudan University, and serves as the Chairman of the Pancreatic Surgery Group of the Shanghai Medical Association — a position that reflects his leadership role in shaping pancreatic surgery standards across Shanghai and beyond. With decades of experience managing the most complex pancreatic tumors and difficult diagnostic cases, Prof. Fu is widely regarded as one of China's foremost experts in pancreatic oncology.
Prof. Fu's clinical reputation is built on his ability to take on cases that other centers have declined — including locally advanced tumors requiring vascular reconstruction, recurrent disease after prior surgery, and rare pancreatic neoplasms that demand both surgical creativity and oncological precision. His academic contributions span national guideline development, clinical trial leadership, and mentorship of the next generation of pancreatic surgeons in China.
Clinical Expertise
- Complex pancreatic tumor surgery — including pancreaticoduodenectomy (Whipple procedure), distal pancreatectomy, central pancreatectomy, and total pancreatectomy for multifocal or hereditary disease
- Difficult and refractory case management — second-opinion consultations and surgical planning for patients who have been told surgery is not possible elsewhere
- Vascular involvement & reconstruction — portal vein, superior mesenteric vein, and arterial reconstruction to extend resectability in locally advanced cases
- Minimally invasive pancreatic surgery — laparoscopic and robotic-assisted approaches for eligible patients, reducing surgical trauma and recovery time
- Rare pancreatic neoplasms — including solid pseudopapillary neoplasms (SPN), pancreatic neuroendocrine tumors (pNET), acinar cell carcinoma, and cystic tumors
- Multidisciplinary treatment coordination — integrating surgery with chemotherapy, targeted therapy, immunotherapy, and interventional radiology for comprehensive care
- Postoperative complication management — expert management of pancreatic fistula, delayed gastric emptying, and other complex post-pancreatectomy complications
Why Prof. Fu Deliang?
What distinguishes Prof. Fu is his willingness and ability to operate on cases that most surgeons would not attempt. For international patients who have received a "not operable" verdict at home or at other centers, Prof. Fu's team at Huashan Hospital offers a genuine second opinion backed by one of China's most experienced pancreatic surgery programs.
As Chairman of the Shanghai Medical Association's Pancreatic Surgery Group, Prof. Fu plays a central role in setting clinical standards and coordinating expertise across Shanghai's top hospitals. This network gives his patients access to the full breadth of Shanghai's oncological resources — from advanced imaging and pathology to cutting-edge systemic therapies.
Huashan Hospital's pancreatic surgery program is also known for its rigorous approach to postoperative care, with dedicated protocols for managing the complications that are inherent to major pancreatic resections. For international patients traveling to Shanghai for surgery, this level of postoperative expertise is critical to a safe and successful recovery.
Hospital: Huashan Hospital, Fudan University
Huashan Hospital is one of China's most prestigious academic medical centers, affiliated with Fudan University School of Medicine. Located in central Shanghai, it is consistently ranked among the top hospitals in China and is internationally recognized for its neurosurgery, neurology, and oncology programs. The hospital is equipped with advanced surgical technology including robotic surgery systems, intraoperative imaging, and a dedicated surgical ICU for complex oncological cases.
The Department of Pancreatic Surgery at Huashan operates as a high-volume referral center, receiving complex cases from across China and internationally. Its multidisciplinary tumor board meets regularly to review challenging cases, ensuring that every patient benefits from collective expertise before a treatment plan is confirmed.
About Pancreatic Cancer
Pancreatic cancer remains one of the most difficult cancers to treat, with a global 5-year survival rate of approximately 12%. However, outcomes are significantly better for patients who receive care at high-volume, specialized centers — a fact supported by extensive international research. Key considerations for international patients:
- Surgical resection is the only potentially curative treatment; achieving clear margins (R0) is the most important prognostic factor
- Locally advanced tumors involving major blood vessels are not automatically inoperable — vascular reconstruction by experienced surgeons can achieve curative resection in selected patients
- Neoadjuvant chemotherapy (FOLFIRINOX or gemcitabine + nab-paclitaxel) followed by surgery is increasingly the standard of care for borderline resectable disease
- Pancreatic neuroendocrine tumors (pNETs) have a much better prognosis than pancreatic ductal adenocarcinoma and often benefit from surgical resection even in advanced stages
- Germline genetic testing (BRCA1/2, PALB2, ATM, CDKN2A) is recommended for all pancreatic cancer patients to identify hereditary risk and guide targeted therapy options
- CA 19-9 is the primary tumor marker used for monitoring, though it can be falsely low in patients with Lewis antigen-negative blood types
What to Prepare Before Your Consultation
To enable Prof. Fu's team to conduct a thorough remote case review, international patients should prepare:
- CT scan of the abdomen and pelvis with contrast (DICOM format preferred, within 3 months)
- MRI/MRCP if available, particularly for cystic lesions or biliary involvement
- Pathology report and biopsy or cytology results
- CA 19-9, CEA, and other relevant tumor markers with dates
- Summary of prior treatments (chemotherapy, radiation, prior surgery) with response assessments
- Genetic testing results if available (BRCA, PALB2, MSI/MMR status)
- Current medications and performance status summary
How CMCS Can Help
China Medical Concierge Shanghai (CMCS) coordinates access to Prof. Fu Deliang and the Huashan Hospital pancreatic surgery team for international patients. Our services include:
- Remote case review and pre-consultation assessment before you travel
- Priority appointment scheduling with Prof. Fu's team
- Full translation of medical records, imaging reports, and treatment plans
- In-hospital accompaniment by a dedicated English-speaking case manager
- Accommodation, airport transfer, and logistics coordination in Shanghai
- Post-discharge follow-up and remote consultation support
Contact us to begin your case review:
📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com
댓글 0개